GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Labiana Health SA (XMAD:LAB) » Definitions » Net-Net Working Capital

Labiana Health (XMAD:LAB) Net-Net Working Capital : €-5.22 (As of Dec. 2022)


View and export this data going back to 2022. Start your Free Trial

What is Labiana Health Net-Net Working Capital?

In calculating the Net-Net Working Capital (NNWC), Benjamin Graham assumed that a company's accounts receivable is only worth 75% its value, its inventory is only worth 50% of its value, but its liabilities have to be paid in full. In addition, Graham believed that preferred stock belongs on the liability side of the balance sheet, not as part of capital and surplus. This is a conservative way of estimating the company's value.

Labiana Health's Net-Net Working Capital for the quarter that ended in Dec. 2022 was €-5.22.

The industry rank for Labiana Health's Net-Net Working Capital or its related term are showing as below:

XMAD:LAB's Price-to-Net-Net-Working-Capital is not ranked *
in the Drug Manufacturers industry.
Industry Median: 7.33
* Ranked among companies with meaningful Price-to-Net-Net-Working-Capital only.

Labiana Health Net-Net Working Capital Historical Data

The historical data trend for Labiana Health's Net-Net Working Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Labiana Health Net-Net Working Capital Chart

Labiana Health Annual Data
Trend Dec20 Dec21 Dec22
Net-Net Working Capital
-4.76 -5.55 -5.22

Labiana Health Semi-Annual Data
Dec20 Dec21 Jun22 Dec22
Net-Net Working Capital -4.76 -5.55 -5.05 -5.22

Competitive Comparison of Labiana Health's Net-Net Working Capital

For the Drug Manufacturers - Specialty & Generic subindustry, Labiana Health's Price-to-Net-Net-Working-Capital, along with its competitors' market caps and Price-to-Net-Net-Working-Capital data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Labiana Health's Price-to-Net-Net-Working-Capital Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Labiana Health's Price-to-Net-Net-Working-Capital distribution charts can be found below:

* The bar in red indicates where Labiana Health's Price-to-Net-Net-Working-Capital falls into.



Labiana Health Net-Net Working Capital Calculation

Labiana Health's Net-Net Working Capital (NNWC) per share for the fiscal year that ended in Dec. 2022 is calculated as

Net-Net Working Capital(A: Dec. 2022 )
=(Cash, Cash Equivalents, Marketable Securities+0.75 * Accounts Receivable+0.5 * Total Inventories-Total Liabilities
-Preferred Stock-Minority Interest)/Shares Outstanding (EOP)
=(2.544+0.75 * 8.778+0.5 * 13.833-53.873
-0--0.128)/7.22126
=-5.22

Labiana Health's Net-Net Working Capital (NNWC) per share for the quarter that ended in Dec. 2022 is calculated as

Net-Net Working Capital(Q: Dec. 2022 )
=(Cash, Cash Equivalents, Marketable Securities+0.75 * Accounts Receivable+0.5 * Total Inventories-Total Liabilities
-Preferred Stock-Minority Interest)/Shares Outstanding (EOP)
=(2.544+0.75 * 8.778+0.5 * 13.833-53.873
-0--0.128)/7.22126
=-5.22

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In calculating the Net-Net Working Capital (NNWC), Benjamin Graham assumed that a company's accounts receivable is only worth 75% its value, its inventory is only worth 50% of its value, but its liabilities have to be paid in full.

In addition, Graham believed that preferred stock belongs on the liability side of the balance sheet, not as part of capital and surplus. In "Security Analysis", preferred stock is dubbed "an imperfect creditorship position" that is best placed on the balance sheet alongside funded debt.

This is a conservative way of estimating the company's value.


Labiana Health  (XMAD:LAB) Net-Net Working Capital Explanation

One research study, covering the years 1970 through 1983 showed that portfolios picked at the beginning of each year, and held for one year, returned 29.4 percent, on average, over the 13-year period, compared to 11.5 percent for the S&P 500 Index. Other studies of Graham's strategy produced similar results.

Benjamin Graham looked for companies whose market values were less than two-thirds of their net-net value. They are collected under our Net-Net screener.


Labiana Health Net-Net Working Capital Related Terms

Thank you for viewing the detailed overview of Labiana Health's Net-Net Working Capital provided by GuruFocus.com. Please click on the following links to see related term pages.


Labiana Health (XMAD:LAB) Business Description

Traded in Other Exchanges
N/A
Address
Avenida Europa, 34 1st D, Pozuelo de Alarcon, Madrid, ESP, 28023
Labiana Health SA is a manufacturer of pharmacological products for veterinary use. The company's activities include GMP manufacturer for EU animal and human health industries, manufacturer specialized in sterile and lyophilized dosage forms, source of development, acquisition, and licensing of molecules such as Fosfomycin Trometamol.